논문KCI 등재
Erratum to ‘Evolutionary changes in metabolic dysfunction- associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study’ [Clin Mol Hepatol 2024;30:487-499]
2
조회
0
다운로드
0
인용
0
참고문헌
관련 논문AI추천
Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”Hai Xu, Huikun Wu, Yong Zhou대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to letter to the editor 1 on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”Sang Min Park, Seogsong Jeong, Won Kim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to letter to the editor 2 on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”Sang Min Park, Seogsong Jeong, Won Kim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Erratum to ‘Systemic therapy in advanced hepatocellular carcinoma’ [Clin Mol Hepatol 2023;29:516-519]Joseph C Ahn, Ju Dong Yang, Nguyen H. Tran대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제3호MAFLD or MASLD: Which better represents the prognosis of the steatotic liver population: Letter to the editor on “Evolutionary changes in metabolic dysfunctionassociated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”Jiajun Zhao, Shengfeng Wang, Xiude Fan, Ying Wang, Yongfeng Song대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Risk stratification for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease: Editorial on “High Steatosis-Associated Fibrosis Esti mator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-as sociated steatotic liver disease”Ho Soo Chun, Minjong Lee대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호
이 간행물의 다른 논문 (36건)
Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023Rohit Loomba, Aijaz Ahmed, Donghee Kimpp. 235-238What is new in the 2024 Chinese guidelines for fatty liver disease?Rui-Xu Yang, Jian-Gao Fan, Vincent Wai-Sun Wongpp. 239-246Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”Chih-Cheng Lai, Po-Yu Huang, Chi-Kuei Hsupp. 247-248Classification of microvascular invasion of hepatocellular carcinoma: Different standards, common goals: Letter to the editor on “Classification of microvascular invasion of hepatocellular carcinoma: Correlation with prognosis and magnetic resonance imaging”Weiwei Shi, Hang Jiang, Yihui Rong, Tianshi Ma, Wei Chen, Wei Chenpp. 249-251Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction- associated steatotic liver disease and cirrhosis”Weixiong Zhu, Xuefan Zeng, Zengxi Yang, Yusheng Cheng, Wence Zhoupp. 252-253